ctrl K

Price Alert

Anbio Biotechnology Class... (NNNN)

NASDAQ: NNNN · Real-Time Price · USD

51.19

1.05 (2.09%)

At close: Aug 15, 2025, 10:18 AM

Anbio Biotechnology Class A Ordinary Shares Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	11.76M	9.69M	7.1M	4.18M
Short-Term Investments	n/a	n/a	1.57M	n/a
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	387.44K	62.14K	2.99K	n/a
Receivables	1.06M	1.88M	3.58K	717.5K
Inventory	n/a	n/a	353.87K	n/a
Other Current Assets	n/a	n/a	n/a	n/a
Total Current Assets	18.53M	15.75M	13.94M	4.92M
Property-Plant & Equipment	n/a	n/a	12.06K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	387.44K	62.14K	15.05K	n/a
Total Assets	18.92M	15.81M	13.96M	4.92M
Account Payables	1.63M	827.15K	1.41M	1.89M
Deferred Revenue	n/a	n/a	n/a	490K
Short-Term Debt	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	n/a	n/a	n/a
Total Current Liabilities	1.73M	993.06K	1.41M	2.38M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Liabilities	1.73M	993.06K	1.41M	2.38M
Total Debt	n/a	n/a	n/a	n/a
Common Stock	14.23K	14.23K	n/a	n/a
Retained Earnings	17.17M	14.8M	12.55M	2.54M
Comprehensive Income	n/a	n/a	n/a	n/a
Shareholders Equity	17.19M	14.82M	12.55M	2.54M
Total Investments	n/a	n/a	1.57M	n/a